BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28795308)

  • 1. The mean corpuscular volume as a prognostic factor for colorectal cancer.
    Nagai H; Yuasa N; Takeuchi E; Miyake H; Yoshioka Y; Miyata K
    Surg Today; 2018 Feb; 48(2):186-194. PubMed ID: 28795308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
    Mizuno H; Yuasa N; Takeuchi E; Miyake H; Nagai H; Yoshioka Y; Miyata K
    PLoS One; 2019; 14(8):e0220579. PubMed ID: 31369651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
    Jomrich G; Hollenstein M; John M; Ristl R; Paireder M; Kristo I; Asari R; Schoppmann SF
    Ann Surg Oncol; 2019 Apr; 26(4):976-985. PubMed ID: 30706229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
    Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer.
    Cokmert S; Demir L; Can A; Akyol M; Vedat Bayoglu I; Dirican A; Kucukzeybek Y; Erten C; Oktay Tarhan M
    J BUON; 2014; 19(1):75-82. PubMed ID: 24659646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
    Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of preoperative mean corpuscular volume in colorectal cancer.
    Nakamura K; Seishima R; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
    Jpn J Clin Oncol; 2022 May; 52(6):562-570. PubMed ID: 35253057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy.
    Wei YS; Zhou YG; Wang GY; Liang ZH; Luo MR; Yang TA; Huang J
    Cancer Biomark; 2017 Dec; 20(4):627-635. PubMed ID: 28800321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pre-operative mean corpuscular volume (MCV) in colorectal cancer.
    Shokuhi P; O'Sullivan NJ; Temperley HC; Russell T; McEntee PD; Mehigan BJ; McCormick PH; Gallagher D; Gillham C; Kennedy J; Kelly ME; Larkin JO
    Ir J Med Sci; 2024 Jun; 193(3):1149-1153. PubMed ID: 37943400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer.
    Kozak MM; von Eyben R; Pai JS; Anderson EM; Welton ML; Shelton AA; Kin C; Koong AC; Chang DT
    Am J Clin Oncol; 2017 Aug; 40(4):405-412. PubMed ID: 25756348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
    Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
    J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
    Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
    Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.